XXresearch – Vaginal Dryness

What: A Phase 3, Randomized, Double-blind, Placebocontrolled Multicenter Study to Evaluate the Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal Dryness, a Symptom of Vulvo-vaginal Atrophy (VVA) due to Menopause

Who: Females 40-80

Duration: up to 112 weeks

Name
First Last
Phone
Email
Are you in generally good health?
Are you post menopausal between the ages of 40 to 80?
Do you have moderate to severe vaginal dryness?
Is the vaginal dryness your most bothersome symptom of menopause?
Are you currently taking medication for the vaginal dryness?Untitled